Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

LumiQuick Diagnostics

LumiQuick Diagnostics Inc. develops, manufactures and markets high quality point of care tests and other immunoassay ... read more Featured Products: More products

Download Mobile App





LumiQuick Showcases Expanded Testing Portfolio at MEDICA 2025

By LabMedica International staff writers
Posted on 18 Nov 2025

LumiQuick Diagnostics, Inc. More...

is showcasing its comprehensive range of rapid tests and immunoassay solutions at MEDICA 2025 from 17 to 20 November in Düsseldorf, Germany. Exhibiting in Hall 3, Stand D25-4, the company is presenting its newest developments across infectious-disease testing, drugs-of-abuse screening, cardiac and tumor markers, fertility and vitamin D assays.

LumiQuick’s exhibitor profile emphasizes its QuickProfile rapid-test lines, designed for point-of-care and laboratory use. The infectious-disease portfolio includes assays for malaria, dengue, Zika, chikungunya, influenza A/B, H. pylori, adenovirus, rotavirus, HIV, syphilis, and more, serving both tropical-disease settings and routine clinical workflows. The company’s QuickProfile portfolio also includes rapid tests for cardiac markers, cancer markers, and fertility hormones.

A major focus of the company is its extensive drugs-of-abuse (DOA) collection. The QuickProfile DOA lineup includes single test strips, single-drug card tests, multi-drug panels, and multi-panel cups that detect methamphetamine, cocaine, opiates, THC, fentanyl, synthetic cannabinoids, and many other substances.

At MEDICA 2025, LumiQuick is also highlighting the recently added Aoxre OxisResearch brand, which provides testing solutions for oxidative stress biomarkers, antioxidants, DNA damage, and related indicators. These products simplify the measurement of oxidative, antioxidant, nitrosative, and inflammatory biomarkers that play central roles in a wide range of diseases, including cancer, diabetes, cardiovascular disease, autism, atherosclerosis, stroke, Alzheimer’s, Parkinson’s, and other epidemiologic conditions.

Related Links:
Lumiquick Diagnostics, Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.